These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7879059)

  • 1. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract]   [Full Text] [Related]  

  • 6. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
    J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
    Ueda H; Itoh S; Kusaka M; Isurugi K
    Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

  • 12. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
    Cosenza CA; Tuso PJ; Chapman FA; Middleton YD; Cramer DV; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):59-60. PubMed ID: 8516946
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.
    Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of brequinar sodium for preventing cardiac allograft rejection in primates.
    Makowka L; Tixier D; Chaux A; Hill D; O'Neill P; Eiras-Hreha G; Wu GD; Cunneen S; Cajulis E; Zajac I
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):48-53. PubMed ID: 8516944
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
    Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
    Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.